SkinHealth Systems Inc(SKIN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:10 PM ET (Korea 9/12 05:10)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.23 | Insider Own | 38.76% | Shs Outstand | 130.1M | Perf Week | 0.43% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | 75.69% | Insider Trans | - | Shs Float | 79.7M | Perf Month | 8.23% |
| Enterprise Value | 0.25B | PEG | - | EPS next Q | -0.06 | Inst Own | 51.54% | Short Float | 9.04% | Perf Quarter | 9.1% |
| Income | -0.03B | P/S | 0.31 | EPS this Y | -100% | Inst Trans | -13.8% | Short Ratio | 3.07 | Perf Half Y | -33.96% |
| Sales | 0.29B | P/B | 1.64 | EPS next 5Y | 34.48% | ROA | -5.72% | Short Interest | 7.20M | Perf YTD | -49.64% |
| Book/sh | 0.43 | P/C | 0.44 | EPS past 3/5Y | 11.03% 28.16% | ROE | -43.88% | 52W High | -73.98% ($2.69) | Perf Year | -71.66% |
| Cash/sh | 1.58 | P/FCF | 4.31 | Sales past 3/5Y | -6.32% 20.36% | ROIC | -9.01% | 52W Low | 27.13% ($0.55) | Perf 3Y | -87.2% |
| Dividend Est. | - | EV/EBITDA | 12.56 | EPS Y/Y TTM | -44.06% | Gross Margin | 66.37% | Volatility(W/M) | 7.03% 7.56% | Perf 5Y | -97.32% |
| Dividend TTM | - | EV/Sales | 0.87 | Sales Y/Y TTM | -6.45% | Oper. Margin | -1.47% | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.48 | EPS Q/Q | -169.36% | Profit Margin | -9.8% | RSI (14) | 51.61 | Recom | 3.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.76 | Sales Q/Q | -7.77% | SMA20 | 4.53% ($0.67) | Beta | 1.03 | Target Price | $0.99 |
| Payout | - | Debt/Eq | 6.61 | Earnings | 2026/8/6 | SMA50 | -4.31% ($0.73) | Rel Volume | 0.08 | Prev Close | $0.69 |
| Employees | 613 | LT Debt/Eq | 4.68 | EPS/Sales Surpr. | 20% -3.16% | SMA200 | -29.13% ($0.99) | Avg Volume(3M) | 2.35M | Price | $0.7 |
| IPO | 2020/11/24 | Option/Short | Yes/Yes | Trades | 549 | Volume | 190,328 | Change | 1.45% |
Company
SKIN is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💆 Skin Health Systems (SKIN) is a global medical aesthetics company whose flagship brand is HydraFacial. It operates an integrated ecosystem of skin care devices, consumables, and treatment solutions, supplying beauty and medical channels worldwide—including the United States, Asia-Pacific, Europe, the Middle East, and Latin America.
Over the past 1 year, on the lower side
74% below its 1-year high.
SKIN has weak earning power
Review management risk carefully before investing
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -100.0% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -87.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 51.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
ICVT 0.00%
IWC 0.00%
GSSC 0.00%
VDC 0.00%
OMFS 0.00%It ranks #4 in the industry
Based on market cap of $91M.
SKIN $91M PER -
PG $337B PER 21.9
UL $134B PER 20.7
CL $69B PER 34.3
FAQ
What kind of company is SKIN?
SKIN belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of SKIN?
The market cap of SKIN is approximately $91M, ranking 4,614 within its sector.
What is the 52-week high and low for SKIN?
SKIN has recorded a 52-week high of $2.69 and a low of $0.55.
